Eccentric Exercise and Fatigue in Multiple Sclerosis
Part of paid clinical trials in New York, New York.
- Sponsor
- Hunter College of City University of New York
- Study ID
- NCT06505421
- Status
- Recruiting
Conditions
- Fatigue
- Multiple Sclerosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Resistance training — BEHAVIORALEccentric resistance training and tradional resistance training
Study Details
The goal of this observational study is to compare the impact of eccentric resistance training to traditional resistance training on fatigue in persons with multiple sclerosis (MS). The primary question this study is asking is the following: is eccentric resistance training more fatiguing than traditional resistance training in persons with MS?. Participants will be asked to come for two sessions for two weeks. In the first week, subjects will undergo a bout of either traditional or eccentric resistance training. The next day they will return to assess their level of fatigue. The following week the subject will return and undergo whatever type of training they did not experience the first week, and it's effects on fatigue will again be assessed. The difference between the subjects level of fatigue for either condition will be compared.
Key Dates
- Start date
- Jul 1, 2024
- Status verified
- Jul 2024
- Primary completion
- Dec 30, 2025
- Completion
- Dec 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: Persons with Multiple sclerosisEccentric resistance training , traditional resistance training
Primary Outcome Measure
6-Minute walk test [ Time Frame: Pre-intervention and post intervention for each condition (eccentric and traditional strength training). There is a 36-48 hour period between the pre-intervention and post intervention for each condition ]
Central Contacts
- Herbert Karpatkin, DSc212-396-7115
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hunter College, Physical Therapy Department, City University of New York | New York | New York | 10010 |
Find similar trials in New York, NY
Related Studies
- Genes and Environment in Multiple SclerosisRecruiting · Columbia University · Bethesda, Maryland
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPHASE4 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · New Haven, Connecticut
- Vancomycin Study in Multiple Sclerosis (MS)PHASE1 · Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York